Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction

NCT06096688 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT06096688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06096688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Recruiting
Start date
May 29, 2019
Completion date
June 30, 2027
Enrollment
1,120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, endometrial cancer, hereditary cancer syndromes